May 9, 2007

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

Key Points

Key points are not available for this paper at this time.

Abstract

The quadrivalent vaccine significantly reduced the incidence of HPV-associated anogenital diseases in young women. (ClinicalTrials.gov number, NCT00092521 ClinicalTrials.gov.).

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

Key Points

Abstract

Cite This Study